PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Change of Director's Interest Notice - Rennie, page-16

  1. 585 Posts.
    lightbulb Created with Sketch. 64
    PR made it clear many moons ago, for those that were there, that he is not concerned about the share price, it is not his objective.
    His mission is delivery of iPPS and its benefits to OA patients, of that I now have no doubt.
    His shareholding should show how committed he is, guy could by a small country! This latest buy is chump change but still good to see.

    It's been delayed sure, is it still on mission.. yes.
    There has been nothing, other than delays, to indicate this will not help many people. Results to date are solid, frankly exceptional in my opinion.
    Sure, a capital raise may be on the cards, if more delays get in the way, but I have no doubt the funding will come.
    My opinion only (or course).



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.